IMTX
Immatics NV
NASDAQ · Healthcare · Biotechnology · DE
$6.99
−4.38%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 29.12x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.35x
- Price / sales
- 22.48x
- Price / cash flow
- -4.55x
Enterprise value
- Enterprise value
- $623.6M
- EV / sales
- 13.40x
- EV / EBITDA
- -2.88x
- EV / EBIT
- -2.46x
- Market cap
- $1.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026